NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
2.690
-0.380 (-12.38%)
Oct 19, 2026, 10:38 AM EDT - Market open
NeuroSense Therapeutics Stock Forecast
NRSN's stock price has decreased by -87.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, NeuroSense Therapeutics stock has a consensus rating of "Buy" and an average price target of $78.5. The average 1-year stock price forecast is 2,818.22% higher than the current stock price, while the lowest is $3.50 (+30.11%) and the highest is $180 (+6,591.45%).
Price Target: $78.5 (+2,818.22%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NeuroSense Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Hold Downgrades $3.5 | Hold | Downgrades | $3.5 | +30.11% | Oct 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $52 | Buy | Maintains | $52 | +1,833.09% | Sep 25, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $180 | Buy | Reiterates | $180 | +6,591.45% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.70M
EPS This Year
-4.45
from -8.80
EPS Next Year
-7.12
from -4.45
EPS and Forward PE are based on non-GAAP adjusted numbers.